Navigation Links
Anti-malarial Drug may Help Reduce Risk of Diabetes in Rheumatoid Arthritis Patients

Preliminary research has suggested that use of the anti-malarial drug hydroxychloroquine may help reduce the risk of patients with rheumatoid arthritis developing diabetes .

Type 2 diabetes mellitus affects nearly 8 percent of US adults, and its prevalence has been increasing.

Antimalarials such as hydroxychloroquine, a long-standing safe and inexpensive treatment for an autoimmune disease such as rheumatoid arthritis, theoretically may improve glucose tolerance and prevent diabetes mellitus, according to background information in the article. In vitro and animal studies indicate that antimalarials improve insulin secretion and peripheral insulin sensitivity.

Mary Chester M. Wasko, M.D., M.Sc., of the University of Pittsburgh, Pa., and colleagues examined the association between hydroxychloroquine therapy and risk of diabetes in patients with rheumatoid arthritis.

During the observation period, incident diagnoses of diabetes were reported by 54 patients who had taken hydroxychloroquine and by 171 patients who had never taken it. Analysis indicated that patients who had taken hydroxychloroquine had a 38 percent lower risk of developing diabetes, compared with those who had not taken hydroxychloroquine. This risk was further reduced with increased duration of hydroxychloroquine use. Patients who took hydroxychloroquine for more than four years had a 77 percent lower risk of diabetes compared with those who had never taken hydroxychloroquine.

"We report herein the first evidence, to our knowledge, suggesting that use of hydroxychloroquine is associated with a reduced risk of developing diabetes in patients with rheumatoid arthritis. Moreover, risk reduction increased with duration of hydroxychloroquine exposure, supporting a biological action of this drug on glucose metabolism," the authors wrote.

The researchers also said that 'anti-malarial drugs may have a role in treating rheumato
'"/>




Page: 1 2

Related medicine news :

1. Cheap Anti-malarial Drug
2. Reduced POD linked to fatal asthma attacks
3. Reduced fertility in men who mountain bike
4. Reduce watching TV to prevent Obesity and Diabetes
5. Mammograms Reduce Risk of Dying
6. Night Time Aspirin Regimen Found to Reduce Blood Pressure
7. Reduced Fatigue Boosts Mental Health
8. Gynecological Surgeries Reduce Cancer Risk
9. Drug Reduces Risk of Clogged Arteries, Veins
10. Adding Fish to Diet May Reduce Risk of Alzheimers
11. Sunshine Reduces MS Risk
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... have long been the cornerstones of managing type ...ctually benefits// these patients. Now, a new sys...blood glucose (sugar) levels, increases the body’s...od lipids (fats) while also helping to burn body f...
...Chaudron, M.D., an assistant professor of psychiat...e Medical Center// postpartum depression is a diso...researcher says that the women should be screened ...th. Such an extended period of follow up is very m...
...sweet toothed people, it is very likely that you c...ere isn't one in your reach.// A new study has sho... to consume more fruits than those who prefer salt...marketing professor who led this research felt tha...
... to produce far more doses of bird flu vaccine tha...create a cheap// but effective human bird flu vacc... the vaccine to challenge the H5N1 bird flu by nex...trials. Although most products are still in develo...
Other Medicine News:Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 2Health News:Exercise in Itself Improves Blood Glucose Control in Type 2 Diabetes 3Health News:Early Diagnosis of Postpartum Depression Is Very Essential Among New Mothers 2Health News:Drug Firms Competing to Produce Cheap and Effective bird flu vaccine 2
(Date:10/8/2008)...ovement in patients with pulmonary arterial h... have limited benefit for this debilitating, ...ease, -- Imatinib mesylate, available as Gleeve...to inhibit protein associated with PAH, -- Nova...late in PAH in 2009 EAST HANOVER, N.J., Oct....
(Date:10/7/2008)...e Texas Cardiac Arrhythmia,Institute (TCAI) at St....f,only a few sites in the nation to participate in...o treat persistent atrial fibrillation. TCAI, an,i...er specializing in heart,rhythm disorders, is a pa...exas Cardiovascular Consultants., "This is just a...
(Date:10/7/2008)...l/ -- CEL-SCI Corporation,(NYSE: CVM ) announced ...,Agreement (MTA) with the National Institutes of H...f Dr. Francesco M. Marincola, M.D., to,investigate...environment,caused by CEL-SCI,s cancer drug Multik...Disease and Immunogentics Section, Department of T...
(Date:10/7/2008)... Taligen Therapeutics Inc.,today announced that in...ndidates were presented at the XXII International ...a highlighted the candidates, efficacy in,several ...These highlighted presentations, as well as severa...veal the deep expertise and expanding,knowledge ba...
Breaking Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4EPA Reaches Agreement With American Energy on Clean Air Violations 16725 1St Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia 16723 1St Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia 16723 2St Jude Discovery Offers New Avenues to Understanding an Aggressive Form of Leukemia 16723 3CCA Industries Inc Announces First Quarter Results 16721 1CCA Industries Inc Announces First Quarter Results 16721 2Veterinary Pet Insurance Launches National Pet Parents Day 16719 1Veterinary Pet Insurance Launches National Pet Parents Day 16719 2
...roof of Concept in Mice Transgenic for Human TNFa,.../ -- Debiopharm,Group (Debiopharm), a global indep...alising in oncology and serious medical,conditions...s that,validate the mechanism of action of Debio-0...bits inflammatory processes in animal,models of ac...
...ETHESDA, Md., March 13, 2007--New evidence suggest... reduce your risk of,cardiovascular disease. Resea...dy (FHS), a program of the National Heart,Lung, a...tes of,Health, report that people whose parents li...h blood pressure, high cholesterol,and other risk...
Other Medicine Technology:Preclinical Update - Debio-0512 Therapeutic Vaccine for the,Treatment of Chronic and Acute Inflammatory Conditions 2Framingham Study Shows Parents Who Live Long Pass On Lower Risk of,Cardiovascular Disease 2Framingham Study Shows Parents Who Live Long Pass On Lower Risk of,Cardiovascular Disease 3
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: